India: After Dr Reddy's, Zydus Cadila to buy two products from Teva Pharma

Drug maker Cadila Healthcare Ltd, also known as Zydus Cadila, has acquired two abbreviated new drug applications (ANDA) from Teva Pharmaceutical Industries Ltd that are being divested by Israel-based company as a pre-condition to its acquisition of Allergan Plc.’s generic business.

“The acquisition of these ANDAs is contingent on the closing of the Teva-Allergan generics transaction and approval by the US Federal Trade Commission (FTC),” Zydus said in a statement to the stock exchanges on Monday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter